|
GADD45GIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.67930000000349E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.977040E-04 |
| Normal-vs-Stage2 |
6.338800E-03 |
| Normal-vs-Stage3 |
1.017660E-03 |
| Normal-vs-Stage4 |
3.051800E-02 |
| Stage1-vs-Stage2 |
2.938600E-01 |
| Stage1-vs-Stage3 |
4.906400E-01 |
| Stage1-vs-Stage4 |
3.125800E-01 |
| Stage2-vs-Stage3 |
5.507200E-01 |
| Stage2-vs-Stage4 |
1.370360E-01 |
| Stage3-vs-Stage4 |
1.806180E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.369200E-04 |
| Normal-vs-AfricanAmerican |
7.470500E-02 |
| Normal-vs-Asian |
7.976500E-03 |
| Caucasian-vs-AfricanAmerican |
4.692000E-01 |
| Caucasian-vs-Asian |
7.694400E-01 |
| AfricanAmerican-vs-Asian |
4.653800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.399000E-04 |
| Normal-vs-Female |
9.96709999999679E-05 |
| Male-vs-Female |
7.064000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.391000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.787480E-04 |
| Normal-vs-Age(61-80Yrs) |
5.855300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.379590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.352000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.139800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.678000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.628000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.824800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.140800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.835600E-01 |
| Classical-VS-Follicular |
5.997300E-03 |
| Classical-VS-Other |
4.392400E-01 |
| Classical-VS-Normal |
1.199960E-03 |
| Tall-VS-Follicular |
7.604100E-02 |
| Tall-VS-Other |
5.032000E-01 |
| Tall-VS-Normal |
2.391200E-01 |
| Follicular-VS-Other |
7.947200E-01 |
| Follicular-VS-Normal |
2.63499999997308E-06 |
| Other-VS-Normal |
2.068200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83720000002108E-06 |
| Normal-vs-N1 |
3.684000E-03 |
| N0-vs-N1 |
7.915200E-01 |
|
|
